BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14638406)

  • 1. Multifaceted functions of B cells in chronic hepatitis C virus infection.
    Mondelli MU
    Antiviral Res; 2003 Oct; 60(2):111-5. PubMed ID: 14638406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection and mixed cryoglobulinemia in patients with lymphoproliferative diseases.
    Domingo JM; Romero S; Moreno JA; Domingo JA; Callén L; Gutiérrez M
    Haematologica; 1999 Jan; 84(1):94-6. PubMed ID: 10091402
    [No Abstract]   [Full Text] [Related]  

  • 3. B-cells and mixed cryoglobulinemia.
    Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
    Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture.
    Dammacco F; Gatti P; Sansonno D
    Leuk Lymphoma; 1998 Nov; 31(5-6):463-76. PubMed ID: 9922037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
    Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
    Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
    J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoproliferative diseases and hepatitis C virus infection.
    Hausfater P; Rosenthal E; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viruses and cancers: possible role of hepatitis C virus.
    Ferri C; La Civita L; Zignego AL; Pasero G
    Eur J Clin Invest; 1997 Sep; 27(9):711-8. PubMed ID: 9352239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.
    Defrancesco I; Visentini M; Zibellini S; Minafò YA; Rattotti S; Ferretti VV; Rizzo E; Varettoni M; Frigeni M; Pulsoni A; Casato M; Colantuono S; Rossi M; Candido C; Zerbi C; Bergamini F; Cristinelli C; Fabbri N; Merli M; Zuccaro V; Bruno R; Paulli M; Arcaini L
    Am J Hematol; 2021 Jun; 96(6):E210-E214. PubMed ID: 33755245
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.
    Carbonari M; Caprini E; Tedesco T; Mazzetta F; Tocco V; Casato M; Russo G; Fiorilli M
    J Immunol; 2005 May; 174(10):6532-9. PubMed ID: 15879157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrahepatic manifestations of HCV infection].
    Husa P
    Vnitr Lek; 2016; 62(9 Suppl 2):18-22. PubMed ID: 27723989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV-associated lymphomas.
    Fiorilli M; Mecucci C; Farci P; Casato M
    Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
    Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
    Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.
    Sautto G; Mancini N; Solforosi L; Diotti RA; Clementi M; Burioni R
    Clin Dev Immunol; 2012; 2012():705013. PubMed ID: 22690241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
    Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
    Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
    Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.
    Machida K; Tsukiyama-Kohara K; Sekiguch S; Seike E; Tóne S; Hayashi Y; Tobita Y; Kasama Y; Shimizu M; Takahashi H; Taya C; Yonekawa H; Tanaka N; Kohara M
    Gastroenterology; 2009 Jul; 137(1):285-96, 296.e1-11. PubMed ID: 19362089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous disorders associated with hepatitis C virus infection.
    Cordel N; Chosidow O; Francès C
    Ann Med Interne (Paris); 2000 Feb; 151(1):46-52. PubMed ID: 10761562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
    Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
    J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.